Investment Rating - The report maintains an "Outperform" rating for the Hong Kong stock market [4] Core Viewpoints - The price recovery across the market is evident, with significant differentiation in fundamentals among various sectors [1] - The Hang Seng Index and Hang Seng Composite Index have shown positive performance, with increases of 2.5% and 3.8% respectively [1] - Small-cap stocks outperformed mid and large-cap stocks, indicating a shift in market dynamics [1] Summary by Sections Market Performance - The Hang Seng Index rose by 2.5%, while the Hang Seng Composite Index increased by 3.8% [1] - The performance of different market segments showed that small-cap stocks (Hang Seng Small Cap +3.0%) outperformed mid-cap (Hang Seng Mid Cap +2.6%) and large-cap stocks (Hang Seng Large Cap +2.5%) [1] - Notable sector performances included the Hang Seng Innovation Drug Index (+6.1%) and the Hang Seng Automobile Index (+4.5%) [1] Valuation Levels - The valuation of the Hang Seng Index increased by 1.6% to 11.8x, while the Hang Seng Composite Index rose by 1.8% to 11.7x [2] - Significant valuation increases were observed in the Hang Seng Automobile Index (+5.3% to 13.8x) [2] - Among 30 sectors, 22 saw valuation increases, with notable rises in Light Industry Manufacturing (+6.7%) and Automotive (+5.7%) [2] Earnings Expectations - The earnings per share (EPS) for the Hang Seng Index increased by 0.4%, while the Hang Seng Composite Index saw a 0.5% rise [3] - The earnings expectations showed a mixed trend, with the Hang Seng Biotechnology Index up by 1.3% and the Hang Seng Automobile Index down by 0.7% [3] - A total of 19 sectors experienced upward revisions in EPS, with Steel (+11.6%) and Non-ferrous Metals (+3.6%) leading the increases [3]

Group 1: Economic Structure and Trends - The service and manufacturing sectors are not in opposition but rather have a symbiotic relationship, as evidenced by the increase of over 7 percentage points in the service sector's share of global GDP from 1980 to 1996, while manufacturing remained stable[1] - From 2002 to 2019, both sectors exhibited a synchronized trend of rise and fall, indicating their interdependence rather than a zero-sum game[1] - Manufacturing acts as an incubator for service industries, with many productive services like logistics and R&D initially emerging from within manufacturing firms[1] Group 2: Support and Demand Dynamics - The large service sector constitutes the core consumer base for manufacturing products, creating significant demand for items ranging from medical equipment to educational materials[2] - Services play a crucial role in enhancing human capital, which is essential for the quality of manufacturing inputs, thereby supporting innovation and breakthroughs in the manufacturing sector[2] - The current economic transition in China highlights the need for high-quality development in manufacturing to create more opportunities for productive services like R&D and digital services[2] Group 3: Current Economic Indicators - Fixed asset investment has decreased by 1.70% year-on-year, indicating a contraction in investment activities[4] - Retail sales have shown a modest increase of 2.90% year-on-year, reflecting some resilience in consumer spending[4] - Exports have declined by 1.10% year-on-year, suggesting pressure on external demand[4] - The M2 money supply has grown by 8.21%, indicating a continued expansionary monetary policy[4]

Investment Rating - The investment rating for the company is "Outperform the Market" [6] Core Views - The company reported a 42.5% year-on-year growth in net profit attributable to shareholders for the first half of the fiscal year 2026, driven by product and store efficiency optimization, as well as an increase in gross margin [1][3] - Same-store sales continued to show double-digit growth from October 1 to November 21, indicating a sustained positive trend [1] - The company announced an interim dividend of HKD 0.55 per share, with a payout ratio of 52% [1] Summary by Sections Financial Performance - For the first half of the fiscal year 2026, the company achieved revenue of HKD 6.843 billion, a year-on-year increase of 25.6%, and a net profit of HKD 619 million, reflecting a growth of 42.5% [1] - The gross margin improved by 2 percentage points to 34.7%, reaching a historical high, benefiting from rising gold prices and an increased proportion of high-margin priced jewelry [2] - The retail business revenue grew by 12.8%, accounting for 76.8% of total revenue, while wholesale business revenue surged by 190.6%, making up 16.3% of total revenue [2] Business Segmentation - The revenue from weight-based products increased by 11%, while fixed-price products saw a growth of 67.9%, with the latter's share rising by 8.8 percentage points to 35.7%, and the proportion of priced gold is expected to reach around 25% [2] - The revenue from the mainland China market grew by 54.2%, accounting for 43.6% of total revenue, while revenue from Hong Kong, Macau, and overseas markets increased by 9.9%, making up 56.4% [2] Future Outlook - The company is expected to continue benefiting from product innovation, channel optimization, and accelerated overseas development, with projected net profits of HKD 1.501 billion, HKD 1.787 billion, and HKD 2.028 billion for fiscal years 2026, 2027, and 2028, respectively [3][4] - The price-to-earnings ratio (PE) is projected to be 9.5, 8.0, and 7.1 for the fiscal years 2026, 2027, and 2028, indicating a favorable valuation [3][4]

Investment Rating - The report maintains an "Outperform the Market" rating for the company [6]. Core Insights - The company demonstrated a significant acceleration in revenue growth in Q3, achieving a revenue of 5.797 billion, a year-on-year increase of 28.2%, surpassing previous guidance [2]. - The adjusted operating profit for Q3 was 1.022 billion, up 14.8% year-on-year, while the adjusted net profit reached 767 million, reflecting an 11.7% increase [2]. - The company expects Q4 revenue growth to be between 25% and 30%, with double-digit same-store sales growth anticipated in both China and the U.S. [2]. - The domestic business is benefiting from a large store strategy and refined operations, with same-store sales showing a positive trend [4]. - The overseas business is expanding rapidly, with a net addition of 117 stores in Q3, bringing the total overseas store count to 3,424 [2]. Financial Performance Summary - Q3 revenue for the brand was 5.222 billion, a year-on-year increase of 22.9%, with domestic revenue at 2.909 billion, up 19.3% [2]. - The company forecasts a full-year revenue growth of 25%, with adjusted operating profit expected to be between 3.65 billion and 3.85 billion [4]. - The financial projections for 2023 to 2027 indicate a steady increase in revenue and net profit, with 2023 revenue projected at 13.839 billion, growing to 28.578 billion by 2027 [5]. - The adjusted net profit for 2023 is estimated at 2.253 billion, with a projected increase to 3.257 billion by 2027 [5].

Core Insights - The report highlights that the small-cap growth sector has rebounded, with all four active quantitative strategies outperforming the equity index this week [1][12] - The performance tracking of Guosen Securities' active quantitative strategies shows significant absolute and relative returns across various combinations, indicating strong investment opportunities [1][12] Summary by Strategy Excellent Fund Performance Enhancement Strategy - This strategy achieved an absolute return of 4.01% this week and a year-to-date return of 23.48%, ranking in the 56.53 percentile among active equity funds [1][21] - The strategy aims to outperform the median return of active equity funds by utilizing a quantitative approach based on the holdings of top-performing funds [3][17] Expected Selection Strategy - The expected selection strategy recorded an absolute return of 3.89% this week and 38.59% year-to-date, ranking in the 27.24 percentile among active equity funds [1][29] - This strategy selects stocks based on positive earnings surprises and analyst upgrades, focusing on both fundamental and technical criteria [4][22] Broker's Golden Stock Performance Enhancement Strategy - This strategy achieved an absolute return of 5.02% this week and 33.65% year-to-date, ranking in the 35.37 percentile among active equity funds [1][37] - It utilizes a stock pool from broker recommendations, optimizing the selection to maintain alignment with the performance of the broker's stock pool [5][30] Growth Stability Strategy - The growth stability strategy reported an absolute return of 4.39% this week and 49.35% year-to-date, ranking in the 13.92 percentile among active equity funds [1][42] - This strategy employs a two-dimensional evaluation system for growth stocks, prioritizing those with upcoming earnings announcements to capture potential excess returns [6][38]

Quantitative Models and Construction Methods 1. Model Name: Hong Kong Stock Selection Portfolio Strategy - **Model Construction Idea**: The model is based on a dual-layer selection process that combines fundamental and technical analysis. It aims to identify stocks with both fundamental support and technical resonance, focusing on analyst-recommended stocks with positive earnings revisions, initial coverage, or unexpected positive events in analyst reports[13][14] - **Model Construction Process**: 1. Construct an analyst-recommended stock pool based on the following events: - Analyst upgrades in earnings forecasts - Initial analyst coverage - Analyst report titles indicating unexpected positive events 2. Perform a dual-layer selection process: - **Fundamental Analysis**: Evaluate the fundamental support of the stocks - **Technical Analysis**: Assess the technical resonance of the stocks 3. Select stocks that exhibit both strong fundamentals and technical momentum to construct the Hong Kong Stock Selection Portfolio 4. Backtesting period: 2010-01-01 to 2025-06-30, considering full position and transaction costs 5. Annualized return: 19.11% with an excess return of 18.48% relative to the Hang Seng Index[14][18] - **Model Evaluation**: The model demonstrates strong performance with significant excess returns over the benchmark index, indicating its effectiveness in identifying outperforming stocks[14][18] --- Model Backtesting Results 1. Hong Kong Stock Selection Portfolio - **Annualized Return**: 19.11% - **Excess Return Relative to Hang Seng Index**: 18.48% - **Maximum Drawdown**: 23.73% - **Information Ratio (IR)**: 1.22 - **Tracking Error**: 14.55% - **Return-to-Drawdown Ratio**: 0.78[18] --- Quantitative Factors and Construction Methods 1. Factor Name: Stable New High Stocks Screening - **Factor Construction Idea**: The factor identifies stocks that have recently reached a 250-day high, emphasizing momentum and trend-following strategies. The approach is inspired by research showing that stocks near their 52-week highs tend to outperform those far from their highs[19] - **Factor Construction Process**: 1. Define the 250-day new high distance as: $ 250 \text{ day new high distance} = 1 - \frac{\text{Close}_{t}}{\text{ts\_max}(\text{Close}, 250)} $ - $\text{Close}_{t}$: Latest closing price - $\text{ts\_max}(\text{Close}, 250)$: Maximum closing price over the past 250 trading days - If the latest closing price reaches a new high, the distance is 0; otherwise, it is a positive value indicating the percentage drop from the high[21] 2. Screening criteria: - Stocks must have been listed for more than 15 months - At least 5 buy or overweight ratings from analysts in the past 6 months - Top 20% in terms of 250-day price performance within the sample pool - Price stability: Evaluate price movement smoothness using metrics such as price displacement ratio - Consistency of new highs: Calculate the average 250-day new high distance over the past 120 days and the past 5 days, selecting the top 50 stocks based on these metrics[22] - **Factor Evaluation**: The factor effectively captures momentum and trend-following opportunities in the Hong Kong stock market, with a focus on stocks that exhibit stable price movements and consistent new highs[19][22] --- Factor Backtesting Results 1. Stable New High Stocks Screening - **Selected Stocks**: - **Sector Distribution**: - Cyclical: 6 stocks - Manufacturing: 5 stocks - Financial: 4 stocks - Consumer: 4 stocks - Healthcare: 3 stocks - Technology: 1 stock[21][22] - **Examples of Selected Stocks**: - **China Resources Cement (1313.HK)**: 250-day new high distance: 0%, 250-day return: 120.7%, 20-day return: 60.5% - **China Aluminum International (2600.HK)**: 250-day new high distance: 12.9%, 250-day return: 132.5%, 20-day return: 6.2% - **China Life Insurance (2628.HK)**: 250-day new high distance: 5.1%, 250-day return: 93.0%, 20-day return: 9.5%[21][27]

- The report does not contain any specific quantitative models or factors for analysis[1][2][3] - The report primarily focuses on market performance, sector analysis, concept themes, market sentiment, and institutional activities without detailing quantitative models or factors[4][5][6] - No quantitative model construction, factor development, or backtesting results are provided in the report[7][8][9]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][37][42]. Core Insights - The company reported a revenue growth of 1.4% to 8.93 billion yuan and a net profit growth of 5.3% to 1.19 billion yuan for the first half of the 2025/26 fiscal year [1][10]. - The brand's down jacket segment continues to lead growth, with a revenue increase of 8.3% to 6.57 billion yuan, despite challenges in other segments [1][15]. - The company has successfully reduced inventory by 20.3% and improved cash flow, maintaining a stable dividend payout with a mid-term dividend of 6.3 HKD cents, up 5% year-on-year [2][28]. Summary by Sections Financial Performance - For the first half of the 2025/26 fiscal year, the company achieved a revenue of 89.3 billion yuan, with a net profit of 11.9 billion yuan, reflecting a 1.4% and 5.3% year-on-year increase, respectively [1][10]. - The overall gross margin increased by 0.1 percentage points to 50.0%, driven by the growth in the down jacket business [1][23]. Business Segments - **Brand Down Jackets**: Revenue increased by 8.3% to 6.57 billion yuan, with a gross margin of 59.1%, a decrease of 2.0 percentage points [1][15]. - **OEM Processing**: Revenue decreased by 11.8% to 2.04 billion yuan, but the gross margin improved by 0.4 percentage points to 20.5% [15][23]. - **Women's Wear**: Revenue fell by 18.6% to 250 million yuan, with a gross margin of 59.9% [15][23]. - **Diversified Apparel**: Revenue decreased by 45.3% to 60 million yuan, primarily due to a decline in the school uniform business [16][23]. Strategic Initiatives - The company is focusing on brand leadership and product innovation by collaborating with top international designers to enhance its high-end image and market recognition [3][31]. - Digital transformation efforts include establishing an AI innovation lab in collaboration with Zhejiang University to improve design efficiency [3][32]. - The company is optimizing its channel strategy, with online revenue growth of 2.4% and a net increase of 85 self-operated stores and 285 dealer stores [3][33]. Future Outlook - The company anticipates accelerated growth in the second half of the fiscal year, supported by strong sales performance in the down jacket segment since October [4][37]. - Profit forecasts for FY2026 to FY2028 are projected at 3.91 billion, 4.30 billion, and 4.73 billion yuan, respectively, with year-on-year growth rates of 11.1%, 10.2%, and 10.0% [4][39].

Investment Rating - The report maintains an "Outperform" rating for Alibaba-SW (09988.HK) [5][25] Core Insights - Alibaba's revenue for FY26Q2 reached 247.8 billion yuan, a year-on-year increase of 5%. The Chinese e-commerce group, international digital commerce group, and cloud intelligence group achieved year-on-year growth rates of 16%, 10%, and 34%, respectively, while other segments saw a decline of 25% [1][9] - The adjusted EBITA for the quarter was 9.1 billion yuan, down 78% year-on-year, resulting in an adjusted EBITA margin of 3.7%. The non-GAAP net profit was 10.3 billion yuan, a decrease of 71.7% year-on-year, with a net profit margin of 4.2% [1][9] - Free cash flow for the quarter was a net outflow of 21.8 billion yuan, primarily due to increased investments in flash sales and cloud infrastructure [1][9] Summary by Sections E-commerce Performance - The Chinese e-commerce group's CMR revenue grew by 10% year-on-year in FY26Q2, benefiting from increased technology service fees and improved site penetration rates. Instant retail revenue reached 22.9 billion yuan, up 60% year-on-year [2][13] - The adjusted EBITA for the Chinese e-commerce group was 10.5 billion yuan, down 76% year-on-year, with an adjusted EBITA margin of 7.9%, a decline of 31 percentage points [2][14] - The company is focusing on optimizing user experience while maintaining market share, with logistics costs significantly reduced compared to previous large-scale investments [2][14] Cloud Computing - The cloud intelligence group's revenue for FY26Q2 was 39.8 billion yuan, a year-on-year increase of 34%. Overall revenue, excluding intercompany transactions, grew by 29% year-on-year, with AI-related product revenue continuing to show triple-digit growth [3][15] - The adjusted EBITA margin for the cloud segment was 9.0%, reflecting a slight increase from the previous quarter. Capital expenditures (CAPEX) for the quarter were 31.5 billion yuan, up 70% year-on-year [3][15] - The company anticipates a strong demand for AI over the next three years, with potential for additional CAPEX investments beyond the planned 380 billion yuan [3][15] Financial Projections - Revenue forecasts for FY2026 to FY2028 have been slightly adjusted to 1,046.3 billion yuan, 1,182.3 billion yuan, and 1,293.0 billion yuan, respectively, with minor downward adjustments due to a focus on profitability in international e-commerce [4][25] - Adjusted net profit projections for FY2026 to FY2028 are set at 111.7 billion yuan, 145.0 billion yuan, and 172.0 billion yuan, with slight adjustments reflecting better-than-expected profit improvement in international e-commerce [4][25] - The company is currently trading at a PE ratio of 24 times for FY2026 [4][25]

Investment Rating - The investment rating for the company is "Outperform the Market" [5][3][13] Core Insights - The company has experienced rapid revenue and profit growth driven by original research drugs, and this trend is expected to continue long-term [1][6] - For FY2026, the company projects a revenue growth of 10-15% year-on-year, with a mid-year revenue of 167 billion yuan, representing a 17% increase compared to the previous year [1][6] - The adjusted net profit for FY2025 was 14 billion yuan, a 39% increase year-on-year, with an adjusted net profit margin of 8.1% [2][7] Revenue Summary - The company's self-operated pharmaceutical revenue reached 143 billion yuan in FY2026, up 19% year-on-year, largely due to a 99% increase in SKU supply for B2C retail products [1][6] - E-commerce platform service revenue was 18 billion yuan, an 8% increase year-on-year, with advertising revenue growing over 10% [1][6] - The medical health and digital services segment generated 5 billion yuan, also reflecting an 8% year-on-year growth [1][6] Profit Summary - The adjusted net profit margin improved to 8.1% in FY2025, up 1.3 percentage points year-on-year, with a gross margin of 25.1% [2][7] - The company has reduced its fulfillment cost ratio to 8.2%, down 0.7 percentage points year-on-year, indicating improved operational efficiency [2][7] - For FY2026, the company anticipates a net profit growth of 20-30% year-on-year, with a mid-year profit projection of 1-21% [2][7] Financial Forecasts - Revenue projections for FY2026 to FY2028 have been adjusted to 348 billion, 379 billion, and 410 billion yuan respectively, reflecting a 4% increase from previous estimates [3][13] - The adjusted net profit forecasts for the same period are set at 25 billion, 30 billion, and 34 billion yuan, also a 6% increase from prior estimates [3][13] - The current stock price corresponds to a FY2026 price-to-earnings ratio of 37 times [3][13]